ISSN: 1449-1907International Journal of Medical Sciences
Global reach, higher impact
Int J Med Sci 2023; 20(10):1293-1299. doi:10.7150/ijms.86594 This issue Cite
Research Paper
Radiofrequency catheter ablation for paroxysmal supraventricular tachycardia in children: Insights on its safety and efficacy from a lower middle-income country
1. Department of Cardiology, University Medical Center HCMC, Ho Chi Minh City, Vietnam
2. Department of Cardiology, Children's Hospital 1, Ho Chi Minh City, Vietnam
3. Department of Radiology, Pham Ngoc Thach University of Medicine, Ho Chi Minh City, Vietnam
4. School of Medicine, Vietnam National University, Ho Chi Minh City, Vietnam
Citation:
Dung BT, Nhut NM, Son LC, An BG, Duc NM, Van Phuoc D. Radiofrequency catheter ablation for paroxysmal supraventricular tachycardia in children: Insights on its safety and efficacy from a lower middle-income country. Int J Med Sci 2023; 20(10):1293-1299. doi:10.7150/ijms.86594. https://www.medsci.org/v20p1293.htm
Other stylesAbstract
OBJECTIVE: Radiofrequency catheter ablation (RFCA) is a safe and effective treatment for paroxysmal supraventricular tachycardia in adults. However, data on its use in children, particularly from low- and middle-income countries, are limited. This study aimed to evaluate the safety and efficacy of RFCA in children with paroxysmal supraventricular tachycardia from Vietnam.
METHODS: A prospective study was conducted from January 2009 to July 2016 at the University Medical Center, Ho Chi Minh City, Vietnam. Ninety-five children diagnosed with paroxysmal supraventricular tachycardia were enrolled; 90 patients underwent cardiac electrophysiology and RFCA. The patients were followed up for 3-12 months, with a mean follow-up period of 7.5 ± 2.3 months.
RESULTS: The average age of the patients was 10.5 ± 3 years, with the youngest patient being 4 years old; 46.3% of the patients were female and 53.7% were male. The patients' average weight was 35.2 ± 9.6 kg. Atrioventricular reentrant tachycardia accounted for 72.6% of the cases and atrioventricular nodal reentrant tachycardia for 27.4% of the cases; no patients had atrial tachycardia. The success rate of RFCA was 98.9% (89/90 patients). During the 12-month follow-up, 5.6% of the patients experienced recurrence but were successfully treated with a second ablation. No severe complications were reported during the procedure and follow-up.
CONCLUSIONS: This study found RFCA to be a safe and effective treatment for paroxysmal supraventricular tachycardia in children. It demonstrated a high success rate and low recurrence and complication rates for RFCA in children, thereby highlighting the potential advantages of the procedure as a treatment option.
Keywords: Radiofrequency catheter ablation, children, paroxysmal supraventricular tachycardia
Citation styles
APA
Dung, B.T., Nhut, N.M., Son, L.C., An, B.G., Duc, N.M., Van Phuoc, D. (2023). Radiofrequency catheter ablation for paroxysmal supraventricular tachycardia in children: Insights on its safety and efficacy from a lower middle-income country. International Journal of Medical Sciences, 20(10), 1293-1299. https://doi.org/10.7150/ijms.86594.
ACS
Dung, B.T.; Nhut, N.M.; Son, L.C.; An, B.G.; Duc, N.M.; Van Phuoc, D. Radiofrequency catheter ablation for paroxysmal supraventricular tachycardia in children: Insights on its safety and efficacy from a lower middle-income country. Int. J. Med. Sci. 2023, 20 (10), 1293-1299. DOI: 10.7150/ijms.86594.
NLM
Dung BT, Nhut NM, Son LC, An BG, Duc NM, Van Phuoc D. Radiofrequency catheter ablation for paroxysmal supraventricular tachycardia in children: Insights on its safety and efficacy from a lower middle-income country. Int J Med Sci 2023; 20(10):1293-1299. doi:10.7150/ijms.86594. https://www.medsci.org/v20p1293.htm
CSE
Dung BT, Nhut NM, Son LC, An BG, Duc NM, Van Phuoc D. 2023. Radiofrequency catheter ablation for paroxysmal supraventricular tachycardia in children: Insights on its safety and efficacy from a lower middle-income country. Int J Med Sci. 20(10):1293-1299.
This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.